Key result
COVID-19 hypercoagulopathy presents as isolated basilic vein thrombosis in a young obese male.
Why the study?
COVID-19 infection can cause hypercoagulability leading to thrombosis in uncommon sites, requiring clinician vigilance for thrombotic complications.
Case Report (n=1)
Highlights the potential for COVID-19 to cause hypercoagulability leading to thrombosis in uncommon sites such as the basilic vein.
Answers are grounded in this paper and cite their sources.
May prompt vigilance for atypical-site thrombosis in obese COVID-19 patients; leaves open whether targeted prophylaxis trials are warranted.
COVID-19 has not spared a single system in the human body. Although acute respiratory failure culminating sometimes in death remains the most common manifestation of severe infection, hypercoagulability leading to deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke have also been identified widely. Here, we describe a young patient with a COVID-19 infection who developed right basilic vein thrombosis. This case demonstrates how thrombosis can occur in uncommon sites and how clinicians should be vigilant for thrombotic complications in both the inpatient and outpatient settings.
No takes yet. Share an insight, caveat, or question.
Acharya et al. (2021) conducted a case report in COVID-19 and isolated basilic vein thrombosis (n=1). COVID-19 was evaluated. A 22-year-old morbidly obese male with COVID-19 developed an isolated right basilic vein thrombosis, demonstrating that COVID-19-induced hypercoagulopathy can present in uncommon sites.
Synapse has enriched 10 related papers. Consider them for comparative context: